These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11590875)

  • 1. N-3 fatty acids and cardiac function after myocardial infarction in Denmark.
    Skou HA; Toft E; Christensen JH; Hansen JB; Dyerberg J; Schmidt EB
    Int J Circumpolar Health; 2001 Aug; 60(3):360-5. PubMed ID: 11590875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids.
    Macchia A; Levantesi G; Franzosi MG; Geraci E; Maggioni AP; Marfisi R; Nicolosi GL; Schweiger C; Tavazzi L; Tognoni G; Valagussa F; Marchioli R;
    Eur J Heart Fail; 2005 Aug; 7(5):904-9. PubMed ID: 16087142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction.
    Murcia AM; Hennekens CH; Lamas GA; Jiménez-Navarro M; Rouleau JL; Flaker GC; Goldman S; Skali H; Braunwald E; Pfeffer MA
    Arch Intern Med; 2004 Nov; 164(20):2273-9. PubMed ID: 15534166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction: N-3 PUFA supplementation in acute myocardial infarction.
    Haberka M; Mizia-Stec K; Mizia M; Janowska J; Gieszczyk K; Chmiel A; Zahorska-Markiewicz B; Gąsior Z
    Clin Nutr; 2011 Feb; 30(1):79-85. PubMed ID: 20705373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and n-3 fatty acids in patients with a previous myocardial infarction: a placebo-controlled randomized study.
    Madsen T; Christensen JH; Schmidt EB
    Eur J Nutr; 2007 Oct; 46(7):428-30. PubMed ID: 17676423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study.
    Laake K; Myhre P; Nordby LM; Seljeflot I; Abdelnoor M; Smith P; Tveit A; Arnesen H; Solheim S
    BMC Geriatr; 2014 Jun; 14():74. PubMed ID: 24928284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
    Pitt B; White H; Nicolau J; Martinez F; Gheorghiade M; Aschermann M; van Veldhuisen DJ; Zannad F; Krum H; Mukherjee R; Vincent J;
    J Am Coll Cardiol; 2005 Aug; 46(3):425-31. PubMed ID: 16053953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [n-3 polyunsaturated fatty acids, heart rate variability and ventricular arrhythmias in post-AMI-patients. A clinical controlled trial].
    Christensen JH; Gustenhoff P; Korup E; Aarøe J; Toft E; Møller JM; Rasmussen K; Dyerberg J; Schmidt EB
    Ugeskr Laeger; 1997 Sep; 159(37):5525-9. PubMed ID: 9312922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of n-3 polyunsaturated fatty acid supplementation in patients with rheumatoid arthritis: a 16-week randomized, double-blind, placebo-controlled, parallel-design multicenter study in Korea.
    Park Y; Lee A; Shim SC; Lee JH; Choe JY; Ahn H; Choi CB; Sung YK; Bae SC
    J Nutr Biochem; 2013 Jul; 24(7):1367-72. PubMed ID: 23333088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of omega-3 polyunsaturated fatty acids on inflammatory markers in COPD.
    Matsuyama W; Mitsuyama H; Watanabe M; Oonakahara K; Higashimoto I; Osame M; Arimura K
    Chest; 2005 Dec; 128(6):3817-27. PubMed ID: 16354850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    Saravanan P; Bridgewater B; West AL; O'Neill SC; Calder PC; Davidson NC
    Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):46-53. PubMed ID: 20042769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
    Kooshki A; Taleban FA; Tabibi H; Hedayati M
    Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of n-3 fatty acids on cognitive decline: a randomized, double-blind, placebo-controlled trial in stable myocardial infarction patients.
    Geleijnse JM; Giltay EJ; Kromhout D
    Alzheimers Dement; 2012 Jul; 8(4):278-87. PubMed ID: 21967845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).
    Abbate A; Kontos MC; Grizzard JD; Biondi-Zoccai GG; Van Tassell BW; Robati R; Roach LM; Arena RA; Roberts CS; Varma A; Gelwix CC; Salloum FN; Hastillo A; Dinarello CA; Vetrovec GW;
    Am J Cardiol; 2010 May; 105(10):1371-1377.e1. PubMed ID: 20451681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled long-term study of isosorbide-5-mononitrate therapy in patients with left ventricular dysfunction after acute myocardial infarction.
    Tingberg E; Roijer A; Thilen U; Eskilsson J; Ohlin H
    Am Heart J; 2003 Jan; 145(1):E1. PubMed ID: 12514673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers.
    Din JN; Archer RM; Harding SA; Sarma J; Lyall K; Flapan AD; Newby DE
    Heart; 2013 Feb; 99(3):168-74. PubMed ID: 23184014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
    Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
    Tavazzi L; Maggioni AP; Marchioli R; Barlera S; Franzosi MG; Latini R; Lucci D; Nicolosi GL; Porcu M; Tognoni G;
    Lancet; 2008 Oct; 372(9645):1223-30. PubMed ID: 18757090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction.
    Talwar S; Squire IB; Downie PF; Mccullough AM; Campton MC; Davies JE; Barnett DB; Ng LL
    Eur Heart J; 2000 Sep; 21(18):1514-21. PubMed ID: 10973765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.